Press Releases

Satellite Bio Announces FDA Clearance of IND Application for SB-101 for the Treatment of Urea Cycle Disorders (UCDs) Marking its Transition to a Clinical-Stage Biotechnology Company

Satellite Bio Announces FDA Rare Pediatric Disease Designation for SB-101 for the Treatment of Urea Cycle Disorders (UCDs)

Satellite Bio Appoints Steven Altschuler, MD, as Chair of its Board of Directors

Satellite Bio to Present New Preclinical Data for Company’s Novel Primary Cell-Derived Hepatocytes at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting

Satellite Bio Reveals Pioneering Tissue Therapeutics, Bioengineered Tissues That Restore Organ Function, Bringing Hope Across Diseases